FXYD3 and neoplasm: FXYD3 expression in tumor tissue revealed by immunohistochemistry was an unfavorable prognostic marker in hepatocellular carcinoma [10] and colorectal cancer [10,12], though Jin et al. reported a contradictory prognostic role in colorectal cancer using TCGA database [11].